These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 740112)

  • 41. Erythrocyte glycolysis, 2,3-diphosphoglycerate and adenosine triphosphate concentration in uremic subjects: relationship to extracellular phosphate concentration.
    Lichtman MA; Miller DR
    J Lab Clin Med; 1970 Aug; 76(2):267-79. PubMed ID: 5434006
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of trasylol on the concentration of middle-sized molecules of urea and creatinine in the plasma in acute experimental uremia].
    Madry K; Lutz W; Grande G
    Pol Tyg Lek; 1978 Jan; 33(1):5-8. PubMed ID: 306100
    [No Abstract]   [Full Text] [Related]  

  • 43. Insulin receptor of erythrocytes and glucose metabolism in uremic children.
    Namikawa T; Namikawa T; Fujimoto S; Furuse A; Hattori S; Matsuda I; Nakahara C; Ito H
    Horm Metab Res; 1983 Apr; 15(4):161-6. PubMed ID: 6345310
    [No Abstract]   [Full Text] [Related]  

  • 44. Plasma fibronectin levels in patients with chronic uremia.
    Schena FP; Pertosa G; Germinario C
    Nephron; 1986; 44(4):320-3. PubMed ID: 3540692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
    Milutinović S; Breyer D; Janković M; Stefović A; Molnar V; Mrzljak V; Rocić B
    Proc Eur Dial Transplant Assoc; 1983; 19():763-8. PubMed ID: 6348765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of plasma erythropoietic-stimulating factors in anemic uremic patients.
    GALLAGHER NI; McCARTHY JM; HART KT; LANGE RD
    Blood; 1959 Jun; 14(6):662-7. PubMed ID: 13651338
    [No Abstract]   [Full Text] [Related]  

  • 47. Diphenylhydantoin binding by red blood cells of normal subjects.
    Hansotia P; Keran E
    Neurology; 1974 Jun; 24(6):575-8. PubMed ID: 4857552
    [No Abstract]   [Full Text] [Related]  

  • 48. Red blood cell sodium transport and phosphate release in uremia.
    Swaminathan R
    Nephron; 1984; 37(2):142. PubMed ID: 6728090
    [No Abstract]   [Full Text] [Related]  

  • 49. The influence of uremic acidosis on carbohydrate and lipid metabolism in erythrocytes.
    Rutkowski B; Zdrojewski Z; Górski J; Badzio T; Manitius A
    Przegl Lek; 1985; 42(4):425-7. PubMed ID: 4048534
    [No Abstract]   [Full Text] [Related]  

  • 50. Sodium transport by red blood cells in uremia.
    Villamil MF; Rettori V; Kleeman CR
    J Lab Clin Med; 1968 Aug; 72(2):308-17. PubMed ID: 5671204
    [No Abstract]   [Full Text] [Related]  

  • 51. Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes.
    Guisado R; Arieff AI; Massry SG; Lazarowitz V; Kerian A
    J Clin Invest; 1975 Apr; 55(4):738-45. PubMed ID: 235562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shortened red blood cell survival in uremic patients: beneficial and deleterious effects of dialysis.
    Jacob HS; Eaton JW; Yawata Y
    Kidney Int Suppl; 1975 Jan; (2):139-43. PubMed ID: 1099299
    [No Abstract]   [Full Text] [Related]  

  • 53. Intraerythrocytic cation metabolism in children with uremia undergoing hemodialysis.
    DeSanto NG; Trevisan M; DeColle S; DiMuro M; DeChiara F; Latte M; Franzese A; Iacono R; Capasso G; Capodicasa G
    J Lab Clin Med; 1987 Aug; 110(2):231-6. PubMed ID: 3598350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Retention of medium sized molecules in uremic serum].
    Dall'aglio P; Buzio C; Cambi V; Arisi L; Migone L
    Proc Eur Dial Transplant Assoc; 1972; 9():409-16. PubMed ID: 4668919
    [No Abstract]   [Full Text] [Related]  

  • 55. [Inhibition of red blood cell glucose utilization in uremia].
    Gajdos M; Dzúrik R
    Vnitr Lek; 1974 Oct; 20(10):974-82. PubMed ID: 4420983
    [No Abstract]   [Full Text] [Related]  

  • 56. [Studies on the adenine nucleotides metabolism in uremic erythrocyte (author's transl)].
    Sawada K
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1193-205. PubMed ID: 541880
    [No Abstract]   [Full Text] [Related]  

  • 57. Erythrocyte transport of middle molecular substances.
    Gajdos M; Spustová V; Geryková M; Dzúrik R
    Proc Eur Dial Transplant Assoc; 1981; 18():183-7. PubMed ID: 7329966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and determination of phenylacetylglutamine, a major nitrogenous metabolite in plasma of uremic patients.
    Zimmerman L; Egestad B; Jörnvall H; Bergström J
    Clin Nephrol; 1989 Sep; 32(3):124-8. PubMed ID: 2791363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of ouabain-insensitive red blood cell cation transport in uremic patients.
    Boero R; Quarello F; Guarena C; Piccoli G
    Boll Soc Ital Biol Sper; 1985 Feb; 61(2):243-8. PubMed ID: 3994843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Observations on erythropoietic-stimulating factor (ESF) in the plasma of uremic and nonuremic anemic patients.
    GALLAGHER NI; McCARTHY JM; LANGE RD
    Ann Intern Med; 1960 Jun; 52():1201-12. PubMed ID: 13826088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.